Research and Markets: Expansion of Corporate Hospitals to Drive the $331.7-Million Indian In-Vitro Diagnostics Market to $900.2 Million in 2016, New Report Says

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/b6ed6a/indian_invitro_di) has announced the addition of Frost & Sullivan's new report "Indian In-vitro Diagnostics Market" to their offering.

This Frost & Sullivan research service titled Indian In-vitro Diagnostics Market provides the market size, competitive landscape, and revenue forecast for various segments.

MARKET OVERVIEW

Rising Prevalence of Chronic and Lifestyle Diseases in Rural Areas Creates a Vast Untapped Market for IVD

With a compound annual growth rate (CAGR) of 18.1 percent from 2009 to 2016, in-vitro diagnostics (IVD) has emerged as one of the most profitable markets in the Indian healthcare industry. The improving corporate hospital infrastructure and installation of automated and semi-automated biochemistry, immunology, and hematology equipment have enabled the market to achieve this healthy double-digit growth rate.

While most people in tier I and II cities are aware of the benefits of frequent checkups and preventive healthcare, hospitals are looking to reach out to patients in tier III cities and rural areas, says the analyst of this research. This is a well thought-out move on the part of these hospitals, since lifestyle and communicable diseases are no longer restricted to urban centers, but are spreading to rural areas as well. As a large portion of rural areas do not have even the basic healthcare facilities, several cases remain undiagnosed. These changing disease patterns, rising incidence of diseases, higher healthcare spending, and untapped markets create abundant opportunities for IVD manufacturers.

KEY TOPICS COVERED

  • Executive Summary
  • Research Methodology
  • Scope of Study and Abbreviations
  • Healthcare Industry and Diagnostic Services Landscape
  • Industry Challenges and Market Dynamics
  • Market Segmentation and Forecasts
  • Competitive Landscape
  • Regulations for Diagnostic Equipment
  • Mergers & Acquisitions and Company Profile

MARKET SECTORS

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

  • Biochemistry
  • Immunology
  • Hematology
  • Urine analysis
  • Molecular diagnostics
  • Microbiology

REASONS TO BUY

This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.

For more information visit http://www.researchandmarkets.com/research/b6ed6a/indian_invitro_di

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716